Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management

被引:10
作者
Ohyama, Manabu [1 ]
Matsudo, Kiichi [2 ]
Fujita, Toru [2 ]
机构
[1] Kyorin Univ, Fac Med, Dept Dermatol, 6-20-2 Shinkawa, Mitaka, Tokyo 1810004, Japan
[2] Taisho Pharmaceut Co Ltd, Clin Dev Res & Dev Headquarters Self Medicat, Tokyo, Japan
关键词
alopecia; COVID-19; minoxidil; pandemic; quarantine; APOPTOSIS; MINOXIDIL;
D O I
10.1111/1346-8138.16475
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a pandemic by the World Health Organization, and COVID-19 continues to have a major impact on society. Numerous studies have reported impaired health sequelae after COVID-19 recovery, one of which is hair loss. Individuals with hair loss experience a substantial mental burden, which potentially hinders their social life. However, few studies have systematically analyzed the details including hair loss. Therefore, we conducted a narrative review using PubMed on the frequency, associated comorbidities, disease characteristics, and treatment of hair loss after SARS-CoV-2 infection (HLASCI). Two search strings were used to identify 28 articles. Of note, most of the literature identified on COVID-19 sequelae reported an emergence/occurrence of hair loss. HLASCI is speculated to be composed of a heterogeneous population, with the onset or exacerbation of telogen effluvium (TE), anagen effluvium, androgenetic alopecia (AGA), and alopecia areata (AA) reported as possible underlying mechanisms. Among these, acute TE is thought to be the primary cause of HLASCI, with COVID-19 treatment and TE improvement being considered crucial for HLASCI management. An association between COVID-19 and AA exacerbation has also been implicated with still insufficient evidence. Spontaneous recovery of TE can be expected once infection reduces; however, faster improvement in symptoms is expected to reduce the mental and social burden of patients. An additional search string identified 11 articles about TE treatment which suggested that the use of minoxidil may be beneficial. Topical minoxidil has been widely used for AGA patients, who have been speculated to exhibit poor resistance to SARS-CoV-2. Topical minoxidil may provide relief from HLASCI, but future clinical research is warranted to confirm this observation.
引用
收藏
页码:939 / 947
页数:9
相关论文
共 43 条
[1]  
Abdel Rahman Sherine Hosny, 2020, J Clin Aesthet Dermatol, V13, P37
[2]   The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study [J].
Alessandrini, Aurora Maria ;
Bruni, Francesca ;
Piraccini, Bianca Maria ;
Starace, Michela .
DERMATOLOGY PRACTICAL & CONCEPTUAL, 2021, 11 (03)
[3]  
Almeida G, 2021, J DRUGS DERMATOL, V20, P76, DOI [10.36849/JDD.2021.5676, 10.36849/JDD.5676]
[4]   Efficacy and safety of a new formulation kit (shampoo plus lotion) containing anti-inflammatory and antioxidant agents to treat hair loss [J].
Anzai, Alessandra ;
Pereira, Amanda F. ;
Malaquias, Kleber R. ;
Guerra, Lucas O. ;
Mercuri, Maurizio .
DERMATOLOGIC THERAPY, 2020, 33 (03)
[5]   Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic [J].
Askin, Ozge ;
Ozkoca, Defne ;
Uzuncakmak, Tugba Kevser ;
Serdaroglu, Server .
DERMATOLOGIC THERAPY, 2021, 34 (02)
[6]   Apoptosis in the hair follicle [J].
Botchkareva, Natalia V. ;
Ahluwalia, Gurpreet ;
Shander, Douglas .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (02) :258-264
[7]   Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial - Biochemical) [J].
Cadegiani, Flavio A. ;
McCoy, John ;
Wambier, Carlos Gustavo ;
Goren, Andy .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
[8]   Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis [J].
Cheng, Daryl ;
Calderwood, Claire ;
Skyllberg, Erik ;
Ainley, Adam .
BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
[9]   COVID-19: association with rapidly progressive forms of alopecia areata [J].
FIvenson, David .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (01) :127-127
[10]   Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 [J].
Garrigues, Eve ;
Janvier, Paul ;
Kherabi, Yousra ;
Le Bot, Audrey ;
Hamon, Antoine ;
Gouze, Helene ;
Doucet, Lucile ;
Berkani, Sabryne ;
Oliosi, Emma ;
Mallart, Elise ;
Corre, Felix ;
Zarrouk, Virginie ;
Moyer, Jean-Denis ;
Galy, Adrien ;
Honsel, Vasco ;
Fantin, Bruno ;
Yann Nguyen .
JOURNAL OF INFECTION, 2020, 81 (06) :E4-E6